Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ross

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Endocrinology|January 1, 1986
Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone releaseA Blacklay, A Grossman, R J Ross, et al.
The Journal of Endocrinology|March 1, 1993
The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteersJ P Miell, A M Taylor, J Jones, et al.
Clinical Endocrinology|February 15, 2000
Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidismR C Jenkins, R Valcavi, M Zini, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1997
A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding proteinR J Ross, N Esposito, X Y Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
High-dose leptin activates human leukocytes via receptor expression on monocytesH Zarkesh-Esfahani, G Pockley, R A Metcalfe, et al.
Clinical Endocrinology|August 1, 1990
Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretionR J Ross, J M Kirk, S Tsagarakis, et al.
British Journal of Cancer|February 9, 2006
High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screeningD M Greenfield, J Wright, J E Brown, et al.
Lancet (London, England)|January 3, 1987
Treatment of growth-hormone deficiency with growth-hormone-releasing hormoneR J Ross, C Rodda, S Tsagarakis, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
New growth hormone receptor exon 9 mutation causes genetic short statureR M Ayling, R J Ross, P Towner, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-alpha, interleukin-6, and interferon-gamma) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stressS H Zarkesh-Esfahani, O Kolstad, R A Metcalfe, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Endocrinology|January 1, 1986
Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone releaseA Blacklay, A Grossman, R J Ross, et al.
The Journal of Endocrinology|March 1, 1993
The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteersJ P Miell, A M Taylor, J Jones, et al.
Clinical Endocrinology|February 15, 2000
Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidismR C Jenkins, R Valcavi, M Zini, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1997
A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding proteinR J Ross, N Esposito, X Y Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
High-dose leptin activates human leukocytes via receptor expression on monocytesH Zarkesh-Esfahani, G Pockley, R A Metcalfe, et al.
Clinical Endocrinology|August 1, 1990
Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretionR J Ross, J M Kirk, S Tsagarakis, et al.
British Journal of Cancer|February 9, 2006
High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screeningD M Greenfield, J Wright, J E Brown, et al.
Lancet (London, England)|January 3, 1987
Treatment of growth-hormone deficiency with growth-hormone-releasing hormoneR J Ross, C Rodda, S Tsagarakis, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|April 2, 1999
New growth hormone receptor exon 9 mutation causes genetic short statureR M Ayling, R J Ross, P Towner, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-alpha, interleukin-6, and interferon-gamma) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stressS H Zarkesh-Esfahani, O Kolstad, R A Metcalfe, et al.
Pageof 16